Prognostic value of syncope in the presentation of pulmonary embolism;El síncope como forma de presentación de la embolia de pulmón: Valor pronóstico

Archivos de Bronconeumologia

Volumn 41, Issue 7, 2005, Pages 385-388

  Jimenez D ^a,c   Diaz G ^b   Valle, M ^a   Marti D ^a   Escobar, C ^a   Vidal, R ^a   Picher, J ^a   Sueiro, A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Hospital de la Zarzuela   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Death; Pulmonary embolism; Recurrences; Syncope

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; SYNCOPE;

EID: 23044434439     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076969     Document Type: Article

References (26)

1. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med. 1991;151:933-8.
2. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet. 2003;362:523-6.
3. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000;160:769-74.
4. Collado A, Villalta J, Bombí JA, Ingelmo M. Valor diagnóstico de los factores asociados a tromboembolismo pulmonar. Estudio de 70 casos autopsiados. Med Clin (Barc). 1986;86:265-7.
5. Goldhaber S, Hennekens CH, Evans DA, Newton EC, Godleski JJ. Factors associated with correct ante mortem diagnosis of major pulmonary embolism. Am J Med. 1982;73:822-6.
6. Koutkia P, Wachtel TJ. Pulmonary embolism presenting as syncope: case report and review of the literature. Heart Lung. 1999;28:342-7.
7. Wolfe TR, Allen TL. Syncope as an emergency department presentation of pulmonary embolism. J Emerg Med. 1998;16:27-31.
8. Thames MD, Alpert JS, Dalen JE. Syncope in patients with pulmonary embolism. JAMA. 1977;238:2509-11.
9. De Gregorio MA, Gimeno MJ, Mainar A, Herrera M, Tobio R, Alfonso R, et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol. 2002;13:163-9.
10. De Gregorio MA, Gimeno MJ, Alfonso R, Medrano J, Loyola S, Fava M, et al. Fragmentación mecánica y fibrinólisis intrapulmonar en el tratamiento del tromboembolismo pulmonar masivo con repercusión hemodinámica. Arch Bronconeumol. 2001;37:58-64.
11. Uresandi F, Blanquer J, Conget F, De Gregorio MA, Lobo JL, Otero R, et al. Guía para el diagnóstico, tratamiento y seguimiento de la tromboembolia pulmonar. Arch Bronconeumol. 2004;40:580-94.
12. Büller H, Agnellli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest. 2004;126:401S-28S.
13. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis. JAMA. 1990;263:2753-69.
14. Prandoni P, Cogo A, Bernardi E, Villalta S, Polistena P, Simioni P, et al. A simple approach for detection of recurrent proximal vein thrombosis. Circulation. 1993;88:1730-5.
15. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold-technique-comparison with pulmonary angiography. Radiology. 1992;185:381-7.
16. Kalbfleisch, JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley; 1980.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
18. Calvo-Romero JM, Pérez-Miranda M, Bureo-Dacal P. Syncope in acute pulmonary embolism. Eur J Emerg Med. 2004;11:208-9.
19. Toda R, Vidal F, Benet R, Blavia V, García V, Richard C. Síncope como forma de presentación de un tromboembolismo pulmonar. Estudio de 15 casos. Med Clin (Barc). 1992;98:561-4.
20. Wood KE. Major pulmonary embolism. Chest. 2002;121:877-905.
21. Blackmon JR, Sautter RD, Wagner HN, et al. Urokinase pulmonary embolism trial: phase 1 results. JAMA. 1970;214:2163-72.
22. Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jackle S, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation. 2002;106:1263-8.
23. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955-60.
24. Siragusa S, on behalf of DACUS investigators. Optimal duration of oral anticoagulant therapy after the first episode of the lower limbs: a randomized study based on the recanalization of the vein ultrasonography. J Throm Haemost. 2003;1:P1973.
25. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2004;117:19-25.
26. Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol. 2004;22:1944-8.